GD
GoodRx Holdings, Inc.
GDRX · NASDAQ
$3.38 +0.60% (+$0.02)
1M -1.74%
Market Cap $1.17B
P/E Ratio 72.10x
Div. Yield -
ROE 2.61%
Bulios Fair Price
$3.36
0.6% downside
Current Price
$3.38
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GDRX is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
73 /100
Cheap P/E 72.10x
P/FCF 8.04x
EV/EBITDA 9.52x
Growth
49 /100
Stable Rev. growth 1.30%
Book val. growth 8.89%
FCF growth 21.54%
Profitability
67 /100
Strong Gross margin 88.05%
FCF margin 18.56%
Net margin 2.07%
Quality
13 /100
Poor ROIC 2.64%
Asset turnover 0.34x
ROE 2.61%
Debt
58 /100
Moderate Debt/Equity 0.83x
Net debt/EBITDA 1.63x
Current ratio 1.38x
Stability
42 /100
Moderate Beta 1.60x
Profitable years 2
Rev. volatility 3.92%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GDRX
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Wendy Barnes
Employees
697
Headquarters
Santa Monica
Upcoming events
03 NOV
Earnings
Upcoming earnings report